FEATURED ARTICLES

• Ocular Hypertension In Clinical Trials: Protecting IOP Endpoints From Execution Risk

  Fluctuations in eye pressure measurements can jeopardize trial results. Learn how standardized execution and equipment calibration protect data integrity and regulatory credibility.

• Ophthalmology Clinical Trials: Why Sponsors Are Prioritizing This Therapeutic Area

  Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.

• Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk

  Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.

• How To Reduce Patient Dropout Rates In Clinical Trials

  Sponsors are addressing patient dropout rates by shifting from reactive troubleshooting to proactive protocol designs that minimize participant burden.

• BCVA, OCT, And IOP Testing In Clinical Trials

  Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.

• Site Initiation Visits For Clinical Trials: Ocular Endpoint Planning For Sponsors And CROs

  Learn how expert site initiation visit (SIV) planning masters complex endpoints like OCT and BCVA, eliminates data variability, and prevents the costly need for trial rescue.

• The Clinical Trial Rescue Triage Playbook

  Quickly assess clinical trial risks by evaluating site impact, patient safety, and budget tradeoffs. Turn high-pressure rescue scenarios into clear, actionable paths for your research team.

• At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense

  At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.

• Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site

  Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.

• Why Clinical Trial Demographics Don't Match Real-World Populations

  Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.